BB-OTC

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBB-OTC
Drug Alias Nameornithine transcarbamylase (Bioblast Pharma)BB-OTC
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionOrnithine carbamoyltransferase modulators
TargetsOrnithine carbamoyltransferase
Therapy Area/IndicationsOrnithine Carbamoyltransferase Deficiency Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnlivex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnlivex Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsOrnithine Carbamoyltransferase Deficiency Disease

Other Information

ATC CodeN/A
Related LinksN/A